Advanced in Primitive Neuroectodermal Tumor (PNET)

Dr. Christopher S. Platta

Radiation Oncology
Aspirus Stevens Point Hospital And Clinics, Inc.
900 Illinois Ave, 
Stevens Point, WI 
Clinical Trials:Currently Recruiting for 1 Trial
Accepting New Patients
Advanced in Primitive Neuroectodermal Tumor (PNET)
Aspirus Stevens Point Hospital And Clinics, Inc.
900 Illinois Ave, 
Stevens Point, WI 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Christopher Platta is a Radiation Oncologist in Stevens Point, Wisconsin. Dr. Platta is rated as an Advanced provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). His top areas of expertise are Anal Cancer, Familial Prostate Cancer, Intraductal Papilloma, and Familial Pancreatic Cancer. Dr. Platta is currently accepting new patients.

His clinical research consists of co-authoring 4 peer reviewed articles and participating in 9 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Radiation Oncology
Licenses
Radiology in WI
Hospital Affiliations
Aspirus Stevens Point Hospital & Clinics, Inc.
Aspirus Wausau Hospital
Langlade Hospital
Aspirus Riverview Hospital & Clinics Inc
Aspirus Rhinelander Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Aspirus Arise Health
  • HMO
  • POS
Aspirus Arise Health Plan
  • INSURANCE PLAN
  • OTHER COMMERCIAL
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Security Health
  • EPO
  • HMO
  • INDEMNITY
  • POS
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 8 Less Insurance Carriers -

Locations

ASPIRUS STEVENS POINT HOSPITAL AND CLINICS, INC.
900 Illinois Ave, Stevens Point, WI 54481
Other Locations
ASPIRUS RHINELANDER AND TOMAHAWK HOSPITALS AND CLINICS INC
2251 N Shore Dr, Suite 100, Rhinelander, WI 54501
ASPIRUS RIVERVIEW HOSPITAL AND CLINICS INC
410 Dewey St, Wisconsin Rapids, WI 54494
ASPIRUS WAUSAU HOSPITAL INC
143 S Gibson St, Medford, WI 54451

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

9 Clinical Trials

A Prospective Registry Study to Evaluate the Effect of the DCISionRT Test on Treatment Decisions in Patients with DCIS Following Breast Conserving Therapy
A Prospective Registry Study to Evaluate the Effect of the DCISionRT Test on Treatment Decisions in Patients with DCIS Following Breast Conserving Therapy
Enrollment Status: Recruiting
Publish Date: September 19, 2024
Intervention Type: Device, Other
A Randomized Phase II/III Trial of De-Intensified Radiation Therapy for Patients With Early-Stage, P16-Positive, Non-Smoking Associated Oropharyngeal Cancer
A Randomized Phase II/III Trial of De-Intensified Radiation Therapy for Patients With Early-Stage, P16-Positive, Non-Smoking Associated Oropharyngeal Cancer
Enrollment Status: Active_not_recruiting
Publish Date: October 09, 2025
Intervention Type: Other, Procedure, Drug, Biological, Radiation
Study Drugs: Cisplatin, Nivolumab
Study Phase: Phase 2/Phase 3
Androgen Deprivation Therapy and High Dose Radiotherapy With or Without Whole-Pelvic Radiotherapy in Unfavorable Intermediate or Favorable High Risk Prostate Cancer: A Phase III Randomized Trial
Androgen Deprivation Therapy and High Dose Radiotherapy With or Without Whole-Pelvic Radiotherapy in Unfavorable Intermediate or Favorable High Risk Prostate Cancer: A Phase III Randomized Trial
Enrollment Status: Active_not_recruiting
Publish Date: September 30, 2025
Intervention Type: Radiation
Study Phase: Phase 3
Randomized Phase II/III Trial of Radiotherapy With Concurrent MEDI4736 (Durvalumab) vs. Radiotherapy With Concurrent Cetuximab in Patients With Locoregionally Advanced Head and Neck Cancer With a Contraindication to Cisplatin
Randomized Phase II/III Trial of Radiotherapy With Concurrent MEDI4736 (Durvalumab) vs. Radiotherapy With Concurrent Cetuximab in Patients With Locoregionally Advanced Head and Neck Cancer With a Contraindication to Cisplatin
Enrollment Status: Completed
Publish Date: September 23, 2025
Intervention Type: Other, Biological, Radiation
Study Drugs: Cetuximab, Durvalumab
Study Phase: Phase 2/Phase 3
Phase II-III Trial of Adjuvant Radiotherapy and Androgen Deprivation Following Radical Prostatectomy With or Without Adjuvant Docetaxel
Phase II-III Trial of Adjuvant Radiotherapy and Androgen Deprivation Following Radical Prostatectomy With or Without Adjuvant Docetaxel
Enrollment Status: Active_not_recruiting
Publish Date: May 09, 2025
Intervention Type: Drug, Other, Radiation
Study Drugs: Bicalutamide, Docetaxel, Flutamide, Goserelin acetate, Leuprolide acetate, Nilutamide
Study Phase: Phase 2/Phase 3
Maintenance Systemic Therapy Versus Local Consolidative Therapy (LCT) Plus Maintenance Systemic Therapy for Limited Metastatic Non-Small Cell Lung Cancer (NSCLC): A Randomized Phase II/III Trial
Maintenance Systemic Therapy Versus Local Consolidative Therapy (LCT) Plus Maintenance Systemic Therapy for Limited Metastatic Non-Small Cell Lung Cancer (NSCLC): A Randomized Phase II/III Trial
Enrollment Status: Active_not_recruiting
Publish Date: March 11, 2025
Intervention Type: Radiation, Drug
Study Drugs: Docetaxel, Gemcitabine, Pemetrexed Disodium, Erlotinib Hydrochloride, Pembrolizumab
Study Phase: Phase 2
Phase III Trial of Post-Surgical Single Fraction Stereotactic Radiosurgery (SRS) Compared with Fractionated SRS for Resected Metastatic Brain Disease
Phase III Trial of Post-Surgical Single Fraction Stereotactic Radiosurgery (SRS) Compared with Fractionated SRS for Resected Metastatic Brain Disease
Enrollment Status: Active_not_recruiting
Publish Date: January 15, 2025
Intervention Type: Radiation, Procedure, Other
Study Phase: Phase 3
STEEL: A Randomized Phase II Trial of Salvage Radiotherapy With Standard vs Enhanced Androgen Deprivation Therapy (With Enzalutamide) in Patients With Post-Prostatectomy PSA Recurrences With Aggressive Disease Features
STEEL: A Randomized Phase II Trial of Salvage Radiotherapy With Standard vs Enhanced Androgen Deprivation Therapy (With Enzalutamide) in Patients With Post-Prostatectomy PSA Recurrences With Aggressive Disease Features
Enrollment Status: Active_not_recruiting
Publish Date: October 16, 2024
Intervention Type: Radiation, Drug
Study Drugs: Enzalutamide, Bicalutamide, GnRH analog
Study Phase: Phase 2
Randomized Phase II/III Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for Small Cell Lung Cancer
Randomized Phase II/III Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for Small Cell Lung Cancer
Enrollment Status: Active_not_recruiting
Publish Date: July 17, 2024
Intervention Type: Radiation
Study Phase: Phase 2/Phase 3
View 8 Less Clinical Trials

4 Total Publications

Cervical brachytherapy technique for locally advanced carcinoma of the cervix in a patient with septate uterus.
Cervical brachytherapy technique for locally advanced carcinoma of the cervix in a patient with septate uterus.
Journal: Journal of contemporary brachytherapy
Published: November 18, 2013
Similar Doctors
Distinguished in Primitive Neuroectodermal Tumor (PNET)
Dr. Michael F. Bassetti
Radiation Oncology
Distinguished in Primitive Neuroectodermal Tumor (PNET)
Dr. Michael F. Bassetti
Radiation Oncology

University Of Wisconsin Medical Foundation Inc

410 Dewey St, 
Wisconsin Rapids, WI 
 (16.4 miles away)
715-421-7442
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Michael Bassetti is a Radiation Oncologist in Wisconsin Rapids, Wisconsin. Dr. Bassetti is rated as a Distinguished provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). His top areas of expertise are Pancreatic Cancer, Cholangiocarcinoma (Bile Duct Cancer), Familial Pancreatic Cancer, and Posterior Fossa Tumor. Dr. Bassetti is currently accepting new patients.

Distinguished in Primitive Neuroectodermal Tumor (PNET)
Dr. Joseph A. Bovi
Radiation Oncology
Distinguished in Primitive Neuroectodermal Tumor (PNET)
Dr. Joseph A. Bovi
Radiation Oncology

Radiology Associates Of Appleton Sc

2500 E Capital Dr, 
Appleton, WI 
 (60.9 miles away)
920-364-3600
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Joseph Bovi is a Radiation Oncologist in Appleton, Wisconsin. Dr. Bovi is rated as a Distinguished provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). His top areas of expertise are Meningioma, Astrocytoma, Acoustic Neuroma, and Posterior Fossa Tumor. Dr. Bovi is currently accepting new patients.

Advanced in Primitive Neuroectodermal Tumor (PNET)
Dr. Darryl R. Barton
Radiation Oncology
Advanced in Primitive Neuroectodermal Tumor (PNET)
Dr. Darryl R. Barton
Radiation Oncology
215 N 28th Ave, 
Wausau, WI 
 (30.7 miles away)
715-847-2866
Languages Spoken:
English

Darryl Barton is a Radiation Oncologist in Wausau, Wisconsin. Dr. Barton is rated as an Advanced provider by MediFind in the treatment of Primitive Neuroectodermal Tumor (PNET). His top areas of expertise are Neuroendocrine Carcinoma of the Cervix, Cervical Cancer, Familial Prostate Cancer, and Prostate Cancer.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Platta's expertise for a condition
ConditionClose
    View All 13 Advanced Conditions
    View All 70 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile